Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2017 Jan 31;5(4):998–1007.e2. doi: 10.1016/j.jaip.2016.11.021

Figure 2.

Figure 2

Figure 2

Figure 2

Figure 2

A. Differences in baseline plasma 15-HETE levels between patients with symptom improvement (left) and symptom worsening (right) after four weeks of aspirin therapy. Horizontal bars represent median values.

B. Correlation between baseline plasma 15-HETE levels and ACT score change after four weeks of aspirin treatment. The effect size was determined by using Spearman correlation coefficient and denoted as an r-value.

C. Correlation between baseline plasma 15-HETE levels and FEV1 change after four weeks of aspirin treatment. The effect size was determined by using Spearman correlation coefficient and denoted as an r-value.

D. Correlation between baseline plasma 15-HETE levels and RQLQ score change after four weeks of aspirin treatment. The effect size was determined by using Spearman correlation coefficient and denoted as an r-value.